Discovery of potential cyclooxygenase inhibitors using in silico docking studies

Authors

  • Arumugam Madeswaran Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu
  • Muthuswamy Umamaheswari Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu
  • Kuppuswamy Asokkumar Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu
  • Thirumalaisamy Sivashanmugam Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu
  • Varadharajan Subhadradevi Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu
  • Puliyath Jagannath Department of Pharmacology, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore, Tamil Nadu

DOI:

https://doi.org/10.3329/bjp.v7i1.10007

Keywords:

Binding energy, Inhibition constant, Intermolecular energy, Cyclooxygenase

Abstract

This study deals with the evaluation of the cyclooxygenase inhibitory activity of flavonoids (tangeritin, morin, rhamnetin, theaflavin, pachypodol, eriodictyol, homoeriodictyol, aromadedrin, okanin) using in silico docking studies. In silico docking studies were carried out using AutoDock 4.2. Three important parameters like binding energy, inhibition constant and intermolecular energy were determined. The results showed that all the selected flavonoids showed binding energy ranging between -8.77 kcalmol-1 to -6.10 kcalmol-1 when compared with that of the standard (-8.30 kcalmol-1). Intermolecular energy (-10.56 kcalmol-1 to -7.89 kcalmol-1) and inhibition constant (373.91 nM to 34.03 µM) of the ligands also coincide with the binding energy. All the selected flavonoids contributed cyclooxygenase inhibitory activity because of its structural parameters. These molecular docking analyses could lead to the further development of potent cyclooxygenase inhibitors.

 

 

Downloads

Download data is not yet available.
Abstract
280
Download
165 Read
3

References

Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J. Mol. Biol. 2004; 12: 209-25.

Chang MW, Ayeni C, Breuer S. Virtual screening for HIV protease inhibitors: A comparison of AutoDock 4 and vina. PLoS ONE. PLoS ONE. 2010; 5: 119-55.

Collignon B, Schulz R, Smith JC. Task-parallel message passing interface implementation of AutoDock4 for docking of very large databases of compounds using high-performance supercomputers. J Comput Chem. 2011; 32: 1202-09.

Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ. Virtual Screening with AutoDock: Theory and practice. Exp Opin Drug Disc. 2010; 5: 597-607.

Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995; 33: 1061-80.

Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: Applications of AutoDock. J Mol Recog. 1996; 9: 1-5.

Groot H, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol. 1998; 12: 249-55.

Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta Lipids Lipid Metab. 1996; 1299: 125-40.

Jiang Q, Ames BN. λ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB. 2003; 17: 816-22.

Khodade P, Prabhu R, Chandra N. Parallel implementation of Autodock. J App Crystal. 2007; 40: 598-99.

Konc J, Konc JT, Penca M, Janezic M. Binding-sites prediction assisting protein-protein docking. Acta Chim Slov. 2011; 58: 396-401.

Koppen H. Virtual screening: What does it give us? Curr Opin Drug Disc Dev. 2009; 12: 397-407.

Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Park JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC. Structural basis for selective inhibition of cyclooxygenase 2 by antiinflammatory agents. Nature 1996; 384: 644.

Madeswaran A, Umamaheswari M, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. Docking studies: In silico lipoxygenase inhibitory activity of some commercially available flavonoids. Bangladesh J Pharmacol. 2011; 6: 117-23.

Middleton EJ, Effect of plant flavonoids on immune and inflammatory cell function. Adv Exp Med Biol. 1998; 439: 175-82.

Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson JA. J Comput Chem. 2009; 30: 2785-91.

Park H, Lee J, Lee S. Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins 2006; 65: 549-54.

Schames JR, Henchman RH, Seigel JS, Sotriffer CA, Ni H, McCammon A. Discovery of a Novel Binding Trench in HIV Integrase. J Med Chem. 2004; 47: 1879-81.

Schoichet BK. Virtual screening of chemical libraries. Nature 2004; 43: 862-65.

Seeliger D, Groot BL. Ligand docking and binding site analysis with PyMOL and AutoDock/Vina. J Comput Aided Mol Des. 2010; 24: 417-24.

Smith CJ, Morrow JD, Roberts LJI, Marnett LJ. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun. 1993; 192: 787-93.

Smith RM, DeWitt DL, Garavito RM. Cyclooxygenases: Structural, cellular and molecular biology. Ann Rev Biochem. 2000; 69: 145-52.

Umamaheswari M, Madeswaran A, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. Discovery of potential xanthine oxidase inhibitors using in silico docking studies. Der Pharma Chemica. 2011; 3: 240-47.

Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38: 97-120.

Published

2012-03-26

How to Cite

Madeswaran, A., M. Umamaheswari, K. Asokkumar, T. Sivashanmugam, V. Subhadradevi, and P. Jagannath. “Discovery of Potential Cyclooxygenase Inhibitors Using in Silico Docking Studies”. Bangladesh Journal of Pharmacology, vol. 7, no. 1, Mar. 2012, pp. 21-27, doi:10.3329/bjp.v7i1.10007.

Issue

Section

Research Articles